Bupropion detection in drug testing
Pro Research Analysisby 
Searched over 200M research papers
Bupropion Detection Methods in Drug Testing
Electrochemical and Molecularly Imprinted Polymer Sensors for Bupropion Detection
Recent advances have led to the development of highly sensitive electrochemical sensors for bupropion detection. These sensors use nanocomposites or molecularly imprinted polymers (MIPs) to achieve high specificity and low detection limits. For example, a nanosensor using molecularly imprinted polyaniline, gold nanoparticles, and graphene oxide can detect bupropion in urine and tablet samples with a detection limit as low as 0.5 nM, showing high selectivity even in the presence of similar molecules . Another eco-friendly MIP-based electrochemical sensor demonstrated robust selectivity for bupropion in pharmaceutical forms and spiked human plasma, with a detection limit of 3.18 × 10⁻¹⁴ M, and minimal interference from other drugs like dextromethorphan .
Spectrophotometric and Chromatographic Techniques for Bupropion and Metabolite Quantification
Several spectrophotometric methods have been developed for the simultaneous detection of bupropion and co-formulated drugs in tablets and biological fluids. These methods are cost-effective, sensitive, and do not require complex sample preparation. They can detect bupropion in urine samples with high recovery rates and low variability, making them suitable for bioanalytical applications .
High-performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are also widely used for the quantitative determination of bupropion and its metabolites in plasma and serum. These methods offer high sensitivity, selectivity, and precision, with detection limits as low as 1.75 ng/mL for bupropion and validated performance for routine therapeutic drug monitoring and pharmacokinetic studies Shahi2018Scherf-Clavel2019Cooper1984. Chiral separation techniques using HPLC and capillary electrophoresis have also been developed to distinguish bupropion enantiomers in pharmaceutical formulations and biological samples Castro-Puyana2010Kozlov2022.
False Positives in Immunoassay Drug Screens Due to Bupropion
A significant challenge in drug testing is the potential for bupropion and its metabolites to cause false positive results in immunoassay-based urine drug screens. Case reports and studies have shown that bupropion use can lead to false positives for substances such as MDMA (ecstasy) and amphetamines when using certain immunoassay kits. These false positives are not confirmed by more specific methods like gas chromatography-mass spectrometry (GC-MS) or LC-MS, which can accurately distinguish bupropion from illicit drugs Şahan2023Reidy2011. Therefore, confirmatory testing is essential when immunoassay results are positive in patients known to be taking bupropion.
Conclusion
Bupropion can be reliably detected in drug testing using advanced electrochemical sensors, spectrophotometric methods, and chromatographic techniques, all offering high sensitivity and selectivity in various biological matrices. However, clinicians and laboratory personnel should be aware of the risk of false positives in immunoassay drug screens due to bupropion and its metabolites, and always confirm positive results with more specific analytical methods.
Sources and full results
Most relevant research papers on this topic